Regeneron

Our colleagues choose Regeneron because of the potential to make a meaningful impact in advancing science and medicine. Meet Alex, a powerhouse with a dual degree in Chemical and Biomolecular Engineering from Johns Hopkins University. Alex started as a summer intern, where their entrepreneurial spirit?and passion for innovation shone brightly. ? Today, Alex is a Process Sciences Associate in Industrial Operations and Product Supply (IOPS), where they’re helping to redefine what’s possible in biotechnology. Alex's journey from showcasing their work at our intern poster expo to driving impactful projects as a full-time colleague embodies what we mean when we say “meant for more.” Alex isn’t just hitting milestones; they’re embracing challenges, growing and making a real difference. When reflecting on their experience here, Alex says, "From my time as an intern, and now full time, I know that the work that I do is valued, and I have opportunities here that I wouldn’t have had elsewhere.”? ? Colleagues like Alex inspire us all. They believe in making the impossible possible and are driven by the conviction that the world deserves more—and they’re here to deliver it. Join us in celebrating Alex and their journey below.?

We are committed to advancing our research — because we want more for everyone impacted by blood cancer. With our deep understanding of cancer biology and innovative approaches to developing medicines, we’re facing some of the hardest-to-treat blood cancers head-on, aiming to provide more options to patients in need. #BloodCancerAwarenessMonth #WorldLymphomaAwarenessDay #WLAD2024 Learn more about our mission to transform cancer care: https://bit.ly/4cSylcB

Welcome to The Nucleus, our first audio blog exploring the science that inspires and intrigues us. First up, tune in to hear our host Jeffrey Reid, PhD, VP, Chief Data Officer, Regeneron Genetics Center (RGC) in conversation with Daphne Koller, PhD, Founder and CEO of insitro, examining how AI and ML are being applied to tackle some of the most pressing challenges in the biotech industry, from accelerating drug discovery to unlocking personalized therapeutics.? Listen to the full audio blog here: https://bit.ly/4g0jiAt Stay tuned for future episodes of #TheNucleus, with rotating hosts from Regeneron.

Get ready audio blog listeners! We’re excited to announce our debut of The Nucleus, which will be released on August 29. Join us as our first host and VP, Chief Data Officer, Regeneron Genetics Center (RGC) Jeffrey Reid, PhD, engages in a thought-provoking conversation with Daphne Koller, PhD, Founder and CEO of insitro. Together, they dive into how emerging AI and machine learning tools are shaping equitable scientific discovery. Tune in for a discussion you won't want to miss, and stay tuned for future episodes of #TheNucleus, with rotating hosts from Regeneron.

Meet our IO Bispecifics team: one of our groups who’s changing the way we think about drug development. Using nature as inspiration, they apply their protein engineering?skills to design novel antibody formats and geometries. Generally speaking, they identify opportunities in treatment programs with traditional antibodies and ask the question: How can we make it better?? ? Why we love the?IO Bispecifics?team: They’re serious about their science and they’re serious about their dessert. Cake is a favorite for celebrations, potlucks and when team members return from their travels. It’s also common practice for the social committee to plan team bonding activities to make sure they’re collaborating both in and outside of work.

It’s time for our (?)un-scientific Friday poll. You’ve heard about the old dilemma asking what form of entertainment you'd take with you if you were trapped on an island. Let us know what you’ll have on repeat to keep your brain stimulated in the comments below. ??????

Building community at Regeneron can take on so many forms—including our very own Pickleball Club. George Ehrlich, Principal Scientist and captain of the Pickleball Club, says, “We created the club to promote pickleball as an outlet for better health and well-being and a way for Regeneron colleagues to connect.” The club holds open play at our courts on campus year-round and is a great way to meet colleagues from across the organization. Competition is friendly, and all levels are welcome. Let us know your go-to activity to connect with colleagues in the comments.

Fresh off participating in the amateur athlete marathon race at the Olympics, Peter Belmar is a colleague who is passionate about his career and more. Peter was one of 20,000 participants from around the world selected to run an after-hours race between official Olympic marathons. ? To earn a bib for the Olympic race, Peter had to accumulate 100,000 points by completing a series of running challenges in 2023. ? As a Senior IT Operations Analyst, Peter maintains the computers and instruments in our labs. In his off hours, he’s passionate about health and fitness and being a community champion. He owns a Martial Arts gym, runs a nonprofit fitness organization and is a team captain in the Regeneron Running Club. Peter says, "My goal, no matter what, is to love what I’m doing, whether that’s athletics or supporting operating systems so scientists can do their critical work.” Join us in congratulating Peter in the comments below!

For so many of us, COPD is personal. The burden of the disease reverberates across society. Through a focus on collaboration, innovation, and education, we are working with Sanofi to help address the unmet needs of COPD patients globally. Read more. https://bit.ly/3X2LCLf

When Kaylee Park joined the Corporate Affairs team as an intern this summer, she was hoping her projects would be both meaningful and impactful. She was able to realize those goals right from the start by joining Regeneron's Let’s Get Real About Skin Cancer booth at the Iowa Speedway, where the team engaged with over 8,000 people and distributed 5,000 sun protection kits. "Not only did we raise awareness about certain types of advanced non-melanoma skin cancer, like basal cell carcinoma and cutaneous squamous cell carcinoma, and share important information about skin health, but we were also able to connect with real patients and hear their stories," says Kaylee. Well done, Kaylee!???